文献速递乳腺MR

扩散加权MRI的表观扩散系数图:背景实质强化、纤维腺体组织量和绝经状态对乳腺癌诊断的影响

Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis.
PubMed 文献 · Eur Radiol · 2018-01-12

该研究回顾性分析288例患者共218个恶性与130个良性乳腺病灶,评估背景实质强化、纤维腺体组织量和绝经状态是否影响ADC值鉴别良恶性病变的效能。恶性病灶平均ADC值显著低于良性病灶(1.07±0.21×10⁻³ mm²/s vs. 1.53±0.26×10⁻³ mm²/s,p<0.0001),以1.30×10⁻³ mm²/s为最佳截断值,AUC为0.918,敏感度和特异度均为87%。按背景实质强化水平、纤维腺体组织量或绝经状态分层后,各组间ADC值的敏感度和特异度无统计学显著差异。

要点

  • 恶性病灶平均ADC值显著低于良性病灶,最佳截断值1.30×10⁻³ mm²/s,敏感度和特异度均为87%。
  • 背景实质强化水平、纤维腺体组织量和绝经状态不影响ADC值鉴别良恶性的敏感度和特异度。
  • ADC值可用于不同患者特征下的乳腺癌诊断。

核心结论

  • ADC值鉴别乳腺良恶性病变不受背景实质强化水平、纤维腺体组织量或绝经状态的显著影响。

研究设计与样本

  • 回顾性研究,纳入288例患者的218个恶性病灶和130个良性病灶,评估平均ADC值,按背景实质强化水平(高/低)、纤维腺体组织量(致密/非致密)和绝经状态(绝经前/绝经后)分层比较。

关键影像表现/征象

  • 恶性病灶平均ADC值为1.07±0.21×10⁻³ mm²/s,良性病灶为1.53±0.26×10⁻³ mm²/s,恶性病灶显著低于良性病灶(p<0.0001)。

诊断标准与关键数值

  • 以1.30×10⁻³ mm²/s为最佳截断值,AUC为0.918,敏感度和特异度均为87%。
  • 按背景实质强化水平、纤维腺体组织量或绝经状态分层后,各组间ADC值的敏感度和特异度无统计学显著差异。

临床应用与阅片要点

  • ADC值可用于乳腺良恶性病变的鉴别诊断,且在不同背景实质强化水平、纤维腺体组织量和绝经状态的患者中诊断效能无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the impact of background parenchymal enhancement (BPE), amount of fibroglandular tissue (FGT) and menopausal status on apparent diffusion coefficient (ADC) values in differentiation between malignant and benign lesions.

METHODS: In this HIPAA-compliant study, mean ADC values of 218 malignant and 130 benign lesions from 288 patients were retrospectively evaluated. The differences in mean ADC values between benign and malignant lesions were calculated within groups stratified by BPE level (high/low), amount of FGT (dense/non-dense) and menopausal status (premenopausal/postmenopausal). Sensitivities and specificities for distinguishing malignant from benign lesions within different groups were compared for statistical significance.

RESULTS: The mean ADC value for malignant lesions was significantly lower compared to that for benign lesions (1.07±0.21 x 10-3 mm2/s vs. 1.53±0.26 x 10-3 mm2/s) (p<0.0001). Using the optimal cut-off point of 1.30 x 10-3 mm2/s, an area under the curve of 0.918 was obtained, with sensitivity and specificity both of 87 %. There was no statistically significant difference in sensitivities and specificities of ADC values between different groups stratified by BPE level, amount of FGT or menopausal status.

CONCLUSIONS: Differentiation between benign and malignant lesions on ADC values is not significantly affected by BPE level, amount of FGT or menopausal status.

KEY POINTS: • ADC allows differentiation between benign and malignant lesions. • ADC is useful for breast cancer diagnosis despite different patient characteristics. • BPE, FGT or menopause do not significantly affect sensitivity and specificity.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Horvat JV, Durando M, Milans S, et al. Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis. Eur Radiol. 2018. PMID: 29330631. doi:10.1007/s00330-017-5202-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。